Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New … – GlobeNewswire (press release)

Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New …
GlobeNewswire (press release)
Norovirus is the most common cause of epidemic acute gastroenteritis worldwide, with roughly 700 million cases each year. There are currently no approved therapies for the treatment of chronic norovirus infection or for use as a prevention strategy to

Share this post:

Recent Posts